DetailsChartProfileRisk matrixNewsDocuments

Optimus/  AT0000A326P9  /

Fonds
NAV2024-06-07 Chg.-0.1000 Type of yield Investment Focus Investment company
109.0600EUR -0.09% Full reinvestment Mixed Fund Worldwide Gutmann KAG ▶
GlobeNewswire 06-03 ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet...
GlobeNewswire 05-15 Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024
GlobeNewswire 05-09 Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-06 ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
GlobeNewswire 05-06 Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
GlobeNewswire 04-30 Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research
TeleTrader 04-23 Earnings preview:  Tesla to report Q1 results amid layoffs, deliveries miss
GlobeNewswire 04-11 Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data o...
GlobeNewswire 03-29 Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-28 Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
GlobeNewswire 03-25 Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meet...
GlobeNewswire 03-15 Memes Street Orchestrate Viral Marketing Campaign Capitalizing On Positive Market Sentiment
GlobeNewswire 03-13 Faron’s Financial Statement Release January 1 to December 31, 2023
GlobeNewswire 03-07 Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Busine...
GlobeNewswire 03-05 Immutep Announces First Clinical Data from 90mg Dosing of Efti
GlobeNewswire 02-21 Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
GlobeNewswire 02-14 Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Confere...
GlobeNewswire 02-12 Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized o...
GlobeNewswire 02-09 Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 S...
GlobeNewswire 02-06 Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
GlobeNewswire 02-01 Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
GlobeNewswire 01-26 Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
GlobeNewswire 01-25 Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in...
GlobeNewswire 01-25 Detailed Analysis of BEXMAB Data Provides Insights into Patient Profiles of Responding HMA-Failed MD...
TeleTrader 01-25 Musk: Optimus could be most valuable product ever